Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Lasioglossum leucozonium genome sequencing

PROVIDER: PRJNA1198053 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR29364971_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Lasioglossum leucozonium

Project description:Lasioglossum leucozonium overview

| PRJNA1256593 | ENA

Lasioglossum leucozonium

Project description:Lasioglossum leucozonium alternate haplotype genome sequencing

| PRJNA1122857 | ENA

Lasioglossum leucozonium

Project description:Lasioglossum leucozonium principal haplotype genome sequencing

| PRJNA1122858 | ENA

iyLasLeuo

Project description:Lasioglossum leucozonium (white-zoned furrow bee)

| PRJEB66035 | ENA

Transcriptome sequencing of the halictid, Lasioglossum albipes

Project description:Deep sequencing of mRNA from the halictid Part of the Lasioglossum albipes WGS project (BioProject ID: PRJNA174755) Analysis of ploy(A)+ RNA of different specimens:whole body from the halictid (Lasioglossum albipes)

2012-10-02 | E-GEOD-41247 | biostudies-arrayexpress

Transcriptome sequencing of the halictid, Lasioglossum albipes

Project description:Deep sequencing of mRNA from the halictid Part of the Lasioglossum albipes WGS project (BioProject ID: PRJNA174755)

2012-10-02 | GSE41247 | GEO

iyLasLeuo

Project description:Lasioglossum leucozonium (white-zoned furrow bee), genomic and transcriptomic data

| PRJEB66034 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Lasioglossum albipes

Project description:Lasioglossum albipes Genome sequencing and assembly

| PRJNA174755 | ENA

Project description:Genome sequencing of Lasioglossum albipes adult male

| PRJNA1143928 | ENA